Surrogate reporters for enrichment of cells with nuclease-induced mutations.
about
Site specific mutation of the Zic2 locus by microinjection of TALEN mRNA in mouse CD1, C3H and C57BL/6J oocytesNuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome EditingNeuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9Quantifying on- and off-target genome editingEnhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 SystemSimple and efficient methods for enrichment and isolation of endonuclease modified cellsZFN, TALEN, and CRISPR/Cas-based methods for genome engineeringA robust TALENs system for highly efficient mammalian genome editing.Dynamic caveolae exclude bulk membrane proteins and are required for sorting of excess glycosphingolipids.Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.Production of CMAH Knockout Preimplantation Embryos Derived From Immortalized Porcine Cells Via TALE Nucleases.High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairsA PCR based protocol for detecting indel mutations induced by TALENs and CRISPR/Cas9 in zebrafishIn vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuniTargeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENsProduction of Mutated Porcine Embryos Using Zinc Finger Nucleases and a Reporter-based Cell Enrichment SystemZinc-finger nucleases: how to play two good hands.Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing.TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery.Evaluation of OPEN zinc finger nucleases for direct gene targeting of the ROSA26 locus in mouse embryosMultiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.Photoactivatable CRISPR-Cas9 for optogenetic genome editing.Genome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases.Stability of zinc finger nuclease protein is enhanced by the proteasome inhibitor MG132.A library of TAL effector nucleases spanning the human genome.Simultaneous screening and validation of effective zinc finger nucleases in yeastFunctional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancyGenome engineering of isogenic human ES cells to model autism disorders.Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome EngineeringmRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases.Rh D blood group conversion using transcription activator-like effector nucleases.Death receptor-based enrichment of Cas9-expressing cellsGenome Editing with CRISPR-Cas9: Can It Get Any Better?Precision genome engineering with programmable DNA-nicking enzymes.Efficient PRNP deletion in bovine genome using gene-editing technologies in bovine cells.High-throughput genotyping of CRISPR/Cas9-mediated mutants using fluorescent PCR-capillary gel electrophoresis.In vivo high-throughput profiling of CRISPR-Cpf1 activity.
P2860
Q21559671-D4BAE7FD-5F8E-4F40-8283-A6B2FC9EE9E4Q26770012-A2234EFC-9F06-46E9-93D1-B42750E8D73BQ26777286-1A2903A9-C2B1-40E0-B188-848FE7259D2AQ27011906-B73B75DE-B385-49C3-BEAF-1B4DA2B2F44DQ27015049-0C117586-8E46-4820-8987-87855B5B3420Q28469478-541C90B2-32AB-4D57-8541-1003A0AD19F7Q28538480-35CF7CDD-BEE5-4E5C-A0B7-B2CB1846FAB9Q29615505-E529A4E7-90C4-4278-A325-64D1BEC8AC50Q30563975-76ADD3E4-B5E6-4728-8922-BD5071615067Q30643751-592E4D2E-D24C-4140-ABCE-5585D81F10A4Q33657689-75502C2B-E0D4-44F0-AF2B-A6BF7BA203FBQ33694819-1B005217-E515-499C-B870-60F3B834278EQ33698508-F871A2C1-5A3A-486D-B8D4-B1D2E671C934Q33716823-202F8652-63D6-4998-A132-3AB67F474404Q33807299-40065D96-70C8-4303-809A-37DA66D1DDE3Q33834954-AB7CB709-8376-47CA-B82D-F3CECEB0FDEFQ33885425-18E508E8-E2F4-4C54-B862-9ACE0AD10533Q34113366-47ED1D33-9178-4854-9F93-7B2429552441Q34333858-39589564-CCA4-4F5E-A391-7D763C126A71Q34394269-23691C66-70DE-47B2-B115-CF0B3F9554B6Q34412002-92E64CD1-EF42-4D5E-BB98-EE49112509CFQ34463483-C3E90730-476E-4502-9C68-B6E763B5DA55Q34480785-9B25B763-7474-4023-A3DE-AF57FC1268C4Q34542214-9FC932A7-EF9D-4B50-A603-DA6191FF34E9Q34568279-7DBABB8A-34DD-4D94-9AD0-A9D79B6DD153Q34589235-C0F73BEB-3110-46AC-B05B-60DC222BD03FQ34760684-52E074CA-B485-4A80-86B2-5781B51A21F1Q35050363-C47602AD-9273-4C24-9C3F-B6151BA602D0Q35242522-938AB0EE-16FA-41A7-A81A-237C6C7A3505Q35656697-69B6F87C-89FD-4592-8BB6-DAEE3DBA6FA8Q35725869-FB4BE17D-BD91-458A-91C5-69A5E309157DQ35770689-B176BE65-AB94-42DD-8771-F60F4763C812Q35791576-25C82E47-0975-4D00-ACAD-3C4001F6AA05Q35813538-A1B681D5-8374-4E87-AA75-1FAEF3D231FBQ35925498-B50CBA3A-978B-4060-A3B2-A16730EDADC0Q36025657-6B5635C8-1793-4D02-AB5F-A987A0CFD39AQ36093894-2C4A06C6-C8A7-4794-9535-A5B7F98D9C95Q36147224-CD5D92E4-4683-4E80-8263-F6B4EDD0B9BDQ36205889-D68D024B-6911-46F2-B167-3514577E5F2FQ36227944-04323B92-1430-435F-85DE-B12802E9D2E7
P2860
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@en
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@nl
type
label
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@en
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@nl
prefLabel
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@en
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@nl
P2093
P2860
P356
P1433
P1476
Surrogate reporters for enrichment of cells with nuclease-induced mutations.
@en
P2093
Chorong Jung
Hyojin Kim
Jin-Soo Kim
Sung-Rae Cho
P2860
P2888
P304
P356
10.1038/NMETH.1733
P50
P577
2011-10-09T00:00:00Z